A private broad-profile Research Site with outpatient and inpatient capacity of up to 100 beds.
Suitable for Phase I–III studies and bioequivalence studies.
The Research Site is based on a private medical center and supports inpatient and day-care patient stay, which is important for early-phase and bioequivalence studies.
A private outpatient and day-care Research Site.
Suitable for Phase II–III clinical trials.
The site is based on a private medical center and supports outpatient and day-care visits, protocol-based patient management and coordination of long-term studies.
A private outpatient and day-care Research Site.
Suitable for Phase II–III clinical trials.
The site is suitable for outpatient and day-care visits, patient management according to protocol and coordination of multicenter clinical trials.
A public outpatient and inpatient Research Site focused on neurology.
Suitable for Phase I–III studies and bioequivalence studies.
The Research Site is based on a public institution and provides access to a broad pool of neurology patients.
A public outpatient Research Site.
Suitable for Phase II–IV studies.
The Research Site is based on a public medical organization and provides access to a broad patient pool for therapeutic studies.
A public Research Site in Uzbekistan with capacity of up to 370 beds.
Suitable for Phase I–IV studies and bioequivalence studies.
The Research Site provides access to a broad pool of patients across multiple therapeutic profiles and expands Medical Technologies’ capabilities in Central Asia.